Evidence map›Paper›PMID 30913217›Full record

Trial reportPloS one2019

Effect of information about the benefits and harms of mammography on women's decision making: The InforMa randomised controlled trial.

María José Pérez-Lacasta, Montserrat Martínez-Alonso, Montse Garcia, Maria Sala, Lilisbeth Perestelo-Pérez, Carmen Vidal, Núria Codern-Bové, Maria Feijoo-Cid, Ana Toledo-Chávarri, Àngels Cardona and 4 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03046004 (The Effect of Receiving Information About the Benefits and Harms of Mammography Screening on Women's Decision Making), which is not on this map. Cited by 27 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03046004 nacompletednot on this map

The Effect of Receiving Information About the Benefits and Harms of Mammography Screening on Women's Decision Making

TypeinterventionalSponsorInstitut de Recerca Biomèdica de LleidaRan2016 to 2018Enrolled400ConditionsBreast Cancer ScreeningArmsDecision aid for breast cancer screening, Standard leaflet
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2024
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

María José Pérez-LacastaDepartment of Economics, University Rovira i Virgili, Reus, Spain.
Montserrat Martínez-AlonsoResearch Group on Statistics, Economic Evaluation and Health (GRAEES), Reus, Spain.
Montse GarciaCancer Prevention and Control Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Spain.ORCID 0000-0002-3437-3185
Maria SalaDepartment of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Lilisbeth Perestelo-PérezHealth Services Research on Chronic Patients Network (REDISSEC), Madrid, Spain.
Carmen VidalCancer Prevention and Control Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Spain.
Núria Codern-BovéÀreaQ, Evaluation and Qualitative Research, Barcelona, Spain.
Maria Feijoo-CidDepartment of Nursing, Faculty of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.ORCID 0000-0002-7010-373X
Ana Toledo-ChávarriEvaluation Unit of the Canary Islands Health Service (SESCS), Tenerife, Spain.
Àngels CardonaÀreaQ, Evaluation and Qualitative Research, Barcelona, Spain.
Anna PonsCatalan Health Institut (ICS), Lleida, Spain.
Misericòrdia Carles-LavilaDepartment of Economics, University Rovira i Virgili, Reus, Spain.ORCID 0000-0003-3796-3014
Montserrat RueResearch Group on Statistics, Economic Evaluation and Health (GRAEES), Reus, Spain.ORCID 0000-0002-7862-9365
with the InforMa Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Spain, women invited to breast screening are not usually informed about potential harms of screening. The objective of the InforMa study is to assess the effect of receiving information about the benefits and harms of breast screening on informed choice and other decision-making outcomes, in women approaching the age of invitation to mammography screening.

methodsTwo-stage randomised controlled trial. In the first stage, 40 elementary territorial units of the public healthcare system were selected and randomised to intervention or control. In the second stage, women aged 49-50 years were randomly selected. The target sample size was 400 women. Women in the intervention arm received a decision aid (DA) with detailed information on the benefits and harms of screening. Women in the control arm received a standard leaflet that did not mention harms and recommended accepting the invitation to participate in the Breast Cancer Screening Program (BCSP). The primary outcome was informed choice, defined as adequate knowledge and intentions consistent with attitudes. Secondary outcomes included decisional conflict, worry about breast cancer, time perspective, opinions about the DA or the leaflet, and participation in the BCSP.

resultsIn the intervention group, 23.2% of 203 women made an informed choice compared to only 0.5% of 197 women in the control group (p < 0.001). Attitudes and intentions were similar in both study groups with a high frequency of women intending to be screened, 82.8% vs 82.2% (p = 0.893). Decisional conflict was significantly lower in the intervention group. No differences were observed in confidence in the decision, anxiety, and participation in BCSP.

conclusionsWomen in Spain lack knowledge on the benefits and harms of breast screening. Providing quantitative information on benefits and harms has produced a considerable increase in knowledge and informed choice, with a high acceptance of the informative materials.

trial registrationTrial identifier NCT03046004 at ClinicalTrials.gov registry. Registered on February 4 2017. Trial name: InforMa study.

Indexed as

Decision MakingMammographyBreast NeoplasmsChoice BehaviorDecision Support TechniquesEarly Detection of CancerFemaleHealth Knowledge, Attitudes, PracticeHumansMass ScreeningMiddle AgedOutcome Assessment, Health CarePatient ParticipationRisk AssessmentSpain

Identifiers

PMID30913217
PMCPMC6435150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.